Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

1.64 

-0.03 -1.6%

as of Sep 19 '18

52 Week Range:

1.49 3.07


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. It also provides eye surgery and treatments, family planning, foreign visa medical exams, gastroenterology, general medicine, general surgery, haematology, hand surgery, and heart and kidney treatments. In addition, the company offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal surgery and treatments, sports science, urology, vascular surgery, weight loss, and women's health. Further, it owns and operates Perform, a sports medicine, physiotherapy, and rehabilitation brand; and offers MRI/CT scanning, pathology, and consulting services. As of March 2, 2018, the company offered diagnostics, in-patient, daycase, and out-patient care services through 9 private hospitals, 11 clinics, and 1 Specialist Cancer Care Centre across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 May '09 Apr '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) -0.64
2.43
2.55
2.58
growth rate 100.0% 4.9% 1.2%
Earnings BIT -49.10
-188.70
111.10
114.10
110.40
108.70
92.10
growth rate 0.0% 100.0% 2.7% -3.2% -1.5% -15.3%
Avg.PE 8.16
132.88
31.14
24.45
55.89
growth rate 1,528.4% -76.6% -21.5% 128.6%
ROA -1.00
-5.81
5.29
0.37
3.67
3.17
0.97
growth rate 0.0% 100.0% -93.0% 891.9% -13.6% -69.4%
ROE 1.71
6.13
5.27
1.62
growth rate 258.5% -14.0% -69.3%
ROIC 4.82
4.76
4.05
1.62
growth rate -1.2% -14.9% -60.0%
Cur. Ratio 1.10
1.25
0.31
2.19
2.16
1.76
1.43
growth rate 13.6% -75.2% 606.5% -1.4% -18.5% -18.8%
Quick Ratio 0.92
1.07
0.26
1.70
1.64
1.31
0.91
growth rate 16.3% -75.7% 553.9% -3.5% -20.1% -30.5%
Leverage 1.68
1.66
1.67
1.67
growth rate -1.2% 0.6% 0.0%
Balance Sheet Dec '07 May '09 Apr '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 62.00
52.00
43.00
81.00
85.00
108.80
112.00
105.90
91.90
growth rate -16.1% -17.3% 88.4% 4.9% 28.0% 2.9% -5.5% -13.2%
Acct.Payable 20.00
21.00
21.00
43.00
36.00
38.00
50.80
46.80
49.70
growth rate 5.0% 0.0% 104.8% -16.3% 5.6% 33.7% -7.9% 6.2%
Cur.Assets 173.00
83.00
139.00
211.00
255.00
268.90
240.40
242.60
215.10
growth rate -52.0% 67.5% 51.8% 20.9% 5.5% -10.6% 0.9% -11.3%
Total Assets 1,907.00
382.00
362.00
2,226.00
2,250.00
1,614.80
1,606.10
1,657.20
1,724.40
growth rate -80.0% -5.2% 514.9% 1.1% -28.2% -0.5% 3.2% 4.1%
Cash 89.00
95.00
134.00
111.50
74.50
78.90
67.90
growth rate 2.2% 41.1% -16.8% -33.2% 5.9% -13.9%
Inventory 16.00
13.00
11.00
24.00
26.00
26.20
26.00
29.00
28.10
growth rate -18.8% -15.4% 118.2% 8.3% 0.8% -0.8% 11.5% -3.1%
Cur.Liabilities 198.00
77.00
108.00
192.00
205.00
859.10
109.80
112.50
122.20
growth rate -61.1% 40.3% 77.8% 6.8% 319.1% -87.2% 2.5% 8.6%
Liabilities 2,014.00
194.00
234.00
2,653.00
2,691.00
1,871.00
651.10
659.60
689.10
growth rate -90.4% 20.6% 1,033.8% 1.4% -30.5% -65.2% 1.3% 4.5%
LT Debt 1,507.00
91.00
116.00
2,168.00
2,213.00
859.70
422.20
423.10
424.10
growth rate -94.0% 27.5% 1,769.0% 2.1% -61.2% -50.9% 0.2% 0.2%
Equity -256.20
955.00
997.60
1,035.30
growth rate 100.0% 4.5% 3.8%
Common Shares 401.00
401.00
401.00
318.00
402.00
402.00
401.00
growth rate 0.0% 0.0% -20.7% 26.4% 0.0% -0.3%
Cash Flow Statement Dec '07 May '09 Apr '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 80.00
8.00
7.00
43.00
55.00
53.70
66.60
109.50
149.50
growth rate -90.0% -12.5% 514.3% 27.9% -2.4% 24.0% 64.4% 36.5%
Cash Dividends 12.40
12.40
12.40
14.80
growth rate 0.0% 0.0% 19.4%
Cash From OA 128.00
24.00
23.00
195.00
177.00
99.70
113.00
155.30
177.40
growth rate -81.3% -4.2% 747.8% -9.2% -43.7% 13.3% 37.4% 14.2%
FCF per Share 0.11
0.10
0.08
0.07
growth rate -9.1% -20.0% -12.5%
Sale Purchase of Stock 317.20
317.20
growth rate 0.0%
FCF 48.00
16.00
16.00
152.00
121.00
46.00
46.00
45.00
27.00
4.00
growth rate -66.7% 0.0% 850.0% -20.4% -62.0% 0.0% -2.2% -40.0% -85.2%
Income Statement Dec '07 May '09 Apr '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 369.00
280.00
311.00
674.00
739.00
764.50
856.00
884.80
926.40
growth rate -24.1% 11.1% 116.7% 9.6% 3.5% 12.0% 3.4% 4.7%
Op.Income -127.00
17.00
9.00
-23.00
-130.00
111.10
114.10
110.40
108.70
92.10
growth rate 100.0% -47.1% -100.0% 0.0% 100.0% 2.7% -3.2% -1.5% -15.3%
IBT -49.10
-188.70
-51.90
-7.00
73.60
73.20
growth rate 0.0% 0.0% 0.0% 100.0% -0.5%
Net Income -127.00
17.00
9.00
-23.00
-130.00
102.20
6.00
60.00
53.60
growth rate 100.0% -47.1% -100.0% 0.0% 100.0% -94.1% 900.0% -10.7%
EPS -0.06
-0.32
0.25
0.01
0.14
0.13
0.04
growth rate 0.0% 100.0% -96.0% 1,300.0% -7.1% -69.2%
Gross Profit 147.00
36.00
32.00
353.00
373.00
382.40
419.40
424.80
440.50
growth rate -75.5% -11.1% 1,003.1% 5.7% 2.5% 9.7% 1.3% 3.7%

Quarterly Statements

Item Name Dec '16 Mar '17 Jun '17 Sep '17 Dec '17
Earnings BIT 24.50
26.95
26.95
19.10
19.10
growth rate 10.0% 0.0% -29.1% 0.0%
Balance Sheet Dec '16 Mar '17 Jun '17 Sep '17 Dec '17
Acct.Receivable 91.90
116.80
116.80
growth rate 27.1% 0.0%
Acct.Payable 49.70
95.50
95.50
growth rate 92.2% 0.0%
Cur.Assets 215.10
210.20
210.20
growth rate -2.3% 0.0%
Total Assets 1,724.40
1,750.10
1,750.10
growth rate 1.5% 0.0%
Cash 67.90
64.90
64.90
growth rate -4.4% 0.0%
Inventory 28.10
28.50
28.50
growth rate 1.4% 0.0%
Cur.Liabilities 122.20
144.60
144.60
growth rate 18.3% 0.0%
Liabilities 689.10
715.10
715.10
growth rate 3.8% 0.0%
LT Debt 424.10
424.50
424.50
growth rate 0.1% 0.0%
Equity 1,035.30
1,035.00
1,035.00
growth rate 0.0% 0.0%
Common Shares 4.00
4.00
4.00
growth rate 0.0% 0.0%
Cash Flow Statement Dec '16 Mar '17 Jun '17 Sep '17 Dec '17
Capital Expenditures 38.80
29.75
29.75
growth rate -23.3% 0.0%
Cash Dividends 2.60
5.00
5.00
growth rate 92.3% 0.0%
Cash From OA 44.25
37.85
37.85
growth rate -14.5% 0.0%
FCF 5.45
8.10
8.10
growth rate 48.6% 0.0%
Income Statement Dec '16 Mar '17 Jun '17 Sep '17 Dec '17
Sales 228.45
240.50
240.50
growth rate 5.3% 0.0%
Op.Income 24.50
26.95
26.95
19.10
19.10
growth rate 10.0% 0.0% -29.1% 0.0%
IBT 13.60
6.05
6.05
growth rate -55.5% 0.0%
Net Income 8.95
4.45
4.45
growth rate -50.3% 0.0%
Gross Profit 107.50
115.75
115.75
growth rate 7.7% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (19.89)

YOY Growth Grade:

E (17.25)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 40.95 39.05 0.14
EPS / Growth -6.5% 0.04 9.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 36.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 15.4% 15.4%
Future PE 0.14 23.93 23.93
Future EPS 0.05 0.18 0.18
Value Price
MOS %
0.00
-99.9%
1.04
-36.8%
1.04
-36.8%
MOS Price 0.00 0.52 0.52
IRT 32.85 12.76 12.76

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.